Histologic grading has been a simple and inexpensive method to assess tumor behavior
and prognosis of invasive breast cancer grading, thereby identifying patients at risk for …

Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Gene expression-based recurrence assays are strongly recommended to guide the use of
chemotherapy in hormone receptor-positive, HER2-negative breast cancer, but such testing …

Background After controlling for baseline disease factors, researchers have found that black
women have worse breast cancer survival, and this suggests that treatment differences may …

Purpose To examine (1) the trend and associated factors of Oncotype DX (ODX) use among
hormone receptor-positive (HR+) breast cancer (BC) patients in 2004–2015;(2) the trend of …

Background Genomic assays such as Oncotype Dx (ODX) and MammaPrint are used for risk‐
adapted treatment decisions among patients with early breast cancer. However, to the …

Background Guidelines recommend the use of genomic assays such as OncotypeDx to aid
in decisions regarding the use of chemotherapy for hormone receptor–positive, HER2 …

Background Black women have higher hormone receptor positive (HR+) breast cancer
mortality than White women. Early recurrence rates differ by race, but little is known about …

Background: OncotypeDx is a prognostic and predictive genomic assay used in early-stage
hormone receptor–positive, HER2−(HR+/HER2−) breast cancer. It is used to inform adjuvant …

Third-variable effect refers to the effect transmitted by third-variables that intervene in the
relationship between an exposure and a response variable. Differentiating between the …